{"id":979984,"date":"2026-07-08T22:57:09","date_gmt":"2026-07-09T02:57:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/"},"modified":"2026-07-08T22:57:09","modified_gmt":"2026-07-09T02:57:09","slug":"esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/","title":{"rendered":"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders"},"content":{"rendered":"<div class=\"mw_release\">\n<p>STAMFORD, Conn., July  08, 2026  (GLOBE NEWSWIRE) &#8212; Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Estrella Immunopharma, Inc. (\u201cEstrella\u201d).<\/p>\n<p>This investigation is to determine whether Estrella\u2019s board of directors has violated its fiduciary duties or committed other wrongdoing.<\/p>\n<p>Estrella\u2019s common stock (\u201cEstrella Common Stock\u201d) is listed on Nasdaq under the symbol \u201cESLA.\u201d<\/p>\n<p>Holders of Estrella Common Stock who are interested in learning more about the investigation or their legal rights are encouraged to contact Abbott Cooper PLLC at no cost or obligation.<\/p>\n<p>Abbott Cooper PLLC handles cases on a contingency fee basis, meaning there is no cost to stockholders unless a recovery is obtained.<\/p>\n<p>IF YOU ARE AN ESTRELLA STOCKHOLDER AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, PLEASE CONTACT:<\/p>\n<p>J. Abbott R. Cooper<br \/>Abbott Cooper PLLC<br \/>1266 East Main Street<br \/>Suite 700R<br \/>Stamford, CT 06902<br \/>(475) 477-5031<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JlVCsxpTl0QyJkRGwwQUNOt0ydU00KK00LVIfZFZNU35wBVdShQowdc1h3bgSx6yJt8VxcSPO_1sijN-Zrkb4dZJjZB0Mx49DcQWM144Ajs=\" rel=\"nofollow\" target=\"_blank\">info@abbottlawyer.com<\/a><br \/>https:\/\/abbottlawyer.com\/<\/p>\n<p>Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDRiMTUwYzMtYTFjZi00N2EwLTgzN2UtYjQ2Y2QxNmIyZmFlLTEyNzQ5NjEtMjAyNi0wNy0wOS1lbg==\/tiny\/Abbott-Cooper-PLLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>STAMFORD, Conn., July 08, 2026 (GLOBE NEWSWIRE) &#8212; Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Estrella Immunopharma, Inc. (\u201cEstrella\u201d). This investigation is to determine whether Estrella\u2019s board of directors has violated its fiduciary duties or committed other wrongdoing. Estrella\u2019s common stock (\u201cEstrella Common Stock\u201d) is listed on Nasdaq under the symbol \u201cESLA.\u201d Holders of Estrella Common Stock who are interested in learning more about the investigation or their legal rights are encouraged to contact Abbott Cooper PLLC at no cost or obligation. Abbott Cooper PLLC handles cases on a contingency fee basis, meaning there is no cost to stockholders unless a recovery is obtained. IF YOU ARE AN ESTRELLA STOCKHOLDER AND WOULD LIKE TO &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-979984","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"STAMFORD, Conn., July 08, 2026 (GLOBE NEWSWIRE) &#8212; Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Estrella Immunopharma, Inc. (\u201cEstrella\u201d). This investigation is to determine whether Estrella\u2019s board of directors has violated its fiduciary duties or committed other wrongdoing. Estrella\u2019s common stock (\u201cEstrella Common Stock\u201d) is listed on Nasdaq under the symbol \u201cESLA.\u201d Holders of Estrella Common Stock who are interested in learning more about the investigation or their legal rights are encouraged to contact Abbott Cooper PLLC at no cost or obligation. Abbott Cooper PLLC handles cases on a contingency fee basis, meaning there is no cost to stockholders unless a recovery is obtained. IF YOU ARE AN ESTRELLA STOCKHOLDER AND WOULD LIKE TO &hellip; Continue reading &quot;ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-09T02:57:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders\",\"datePublished\":\"2026-07-09T02:57:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/\"},\"wordCount\":167,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/\",\"name\":\"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE=\",\"datePublished\":\"2026-07-09T02:57:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/","og_locale":"en_US","og_type":"article","og_title":"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders - Market Newsdesk","og_description":"STAMFORD, Conn., July 08, 2026 (GLOBE NEWSWIRE) &#8212; Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Estrella Immunopharma, Inc. (\u201cEstrella\u201d). This investigation is to determine whether Estrella\u2019s board of directors has violated its fiduciary duties or committed other wrongdoing. Estrella\u2019s common stock (\u201cEstrella Common Stock\u201d) is listed on Nasdaq under the symbol \u201cESLA.\u201d Holders of Estrella Common Stock who are interested in learning more about the investigation or their legal rights are encouraged to contact Abbott Cooper PLLC at no cost or obligation. Abbott Cooper PLLC handles cases on a contingency fee basis, meaning there is no cost to stockholders unless a recovery is obtained. IF YOU ARE AN ESTRELLA STOCKHOLDER AND WOULD LIKE TO &hellip; Continue reading \"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-09T02:57:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders","datePublished":"2026-07-09T02:57:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/"},"wordCount":167,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/","name":"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE=","datePublished":"2026-07-09T02:57:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTEzMiM3Njk2OTkzIzIyNjM0MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esla-abbott-cooper-pllc-announces-investigation-on-behalf-of-estrella-immunopharma-inc-stockholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/979984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=979984"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/979984\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=979984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=979984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=979984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}